Veronique Michaud, BPharm, PhD

home / authors / veronique-michaud-bpharm-phd

Articles

June 10th 2022

Revisiting Conclusions on the Empiric Segmentation of High-risk Patients

Veronique Michaud, BPharm, PhD Pamela Dow, MS Jacques Turgeon, BPharm, PhD

The authors provide feedback on generalizations made regarding interventions for high-risk populations in previous research.

September 16th 2021

Association of the MedWise Risk Score With Health Care Outcomes

Veronique Michaud, BPharm, PhD Matt K. Smith, PhD Ravil Bikmetov, PhD Pamela Dow, MS Joshua Johnson, PharmD, BCGP Alan Stein, MD, PhD Stephanie Finnel, PhD Huaichuan Jin, MS Jacques Turgeon, BPharm, PhD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: November 1st 2024 | Updated: November 21st 2024

Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions